The best sequence of anti-HER2 therapy in metastatic breast cancer

Bookmark and Share
Published: 29 Jan 2018
Views: 3912
Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain

Dr Cortes speaks with ecancer at the 10th BGICC in Cairo about treatment sequencing for patients with HER2 positive breast cancer.

He details treatment options assessed in recent trials, including TDM1, trastuzumab emtansine and lapatinib, and control of brain metastasis.

Dr Cortes also gives his position from the conference debate on the suitability of combined adjuvant anti-HER2 therapy, arguing for.